Eli Lilly

Stories 1 - 20 |  Next >>

FDA Approves First Medication as a Sleep Apnea Treatment

Next question will be about Medicare and other insurance coverage

(Newser) - The FDA has granted approval for its first medication for certain patients with sleep apnea—the weight-loss drug Zepbound. The decision could lead to expanded insurance coverage of the medication, CNBC reports; plans often don't include weight-loss drugs. Eli Lilly, the manufacturer, said Friday that Zepbound should be used...

Eli Lilly to Test Weight-Loss Drugs on Addiction

Company's CEO indicates they'll start testing Zepbound for other forms of treatment in 2025

(Newser) - Earlier this week, Eli Lilly announced it was teaming up with telehealth provider Ro to boost access to Zepbound, one of its weight-loss medications. Now, the pharmaceuticals giant is revealing more plans for its blockbuster drug, noting it wants to start testing Zepbound in 2025 as a treatment not only...

On Alzheimer's, an Advance 'We've All Been Waiting For'

Eli Lilly's donanemab, sold as Kisunla, gets the FDA green light to help slow disease progression

(Newser) - Last summer, the Food and Drug Administration gave the thumbs-up to Leqembi, the first drug shown to slow the progression of Alzheimer's disease. Now, almost a year to the day after that move, the government agency has greenlit a second drug: Eli Lilly's donanemab, sold under the brand...

FDA Delays Approval of Eli Lilly's Alzheimer's Drug
FDA Stalls on New
Alzheimer's Drug
Mar 8, 2024 8:55 AM CST

FDA Stalls on New Alzheimer's Drug

'We were not expecting this,' says Eli Lilly president

(Newser) - Eli Lilly's experimental Alzheimer's drug is facing yet another delay on the path toward FDA approval. The company's donanemab medication was first expected to be cleared last year and later by the end of this month. However, the drugmaker announced Friday that approval isn't expected until...

It's Forecast to Be Bestselling Drug Ever. Now, a Big Caveat
It's Forecast to Be Bestselling
Drug Ever. Now, a Big Caveat
IN CASE YOU MISSED IT
Dec 16, 2023 6:30 AM CST

It's Forecast to Be Bestselling Drug Ever. Now, a Big Caveat

Study results show patients who went off Zepbound for a year regained half of weight lost

(Newser) - The full results from Eli Lilly's study of its newly approved weight-loss drug Zepbound serve as a splash of cold water in the face of those who believed a few dozen weekly injections would cause pounds to melt off and stay off. The FDA approved Zepbound, with the active...

It's the 'Most Efficacious Drug Ever Approved for Obesity'

FDA approves Zepbound, new version of diabetes drug Mounjaro

(Newser) - A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, US regulators announced Wednesday. NBC News reports the FDA approved Eli Lilly's Zepbound, or tirzepatide, a drug that helped dieters lose 22.5% of their body weight (or 52 pounds) in its phase...

Diabetes Drug Helped Dieters Lose Quarter of Body Weight
This Drug Is Like a 'Medical
Gastric Bypass' for Weight Loss
IN CASE YOU MISSED IT
Oct 21, 2023 12:10 PM CDT

This Drug Is Like a 'Medical Gastric Bypass' for Weight Loss

Experts say Eli Lilly diabetes drug Mounjaro, aka tirzepatide, holds potential for treating obesity

(Newser) - The medicine in the diabetes drug Mounjaro helped people with obesity or who are overweight lose at least a quarter of their body weight, or about 60 pounds on average, when combined with intensive diet and exercise, a new study shows. By comparison, a group of people who also dieted...

Medicare Will Target These 10 Drugs for Price Cuts

Biden administration to negotiate 'lowest maximum fair price' for Jardiance, Eliquis, others

(Newser) - The popular diabetes treatment Jardiance and the blood thinner Eliquis are among the first drugs that will be targeted for price negotiations in an effort to cut Medicare costs, reports the AP . President Biden's administration on Tuesday released a list of 10 drugs for which the federal government will...

New Drug Poised to Take Weight-Loss Throne

Eli Lilly's Mounjaro is outperforming Ozempic in clinical trials

(Newser) - Get ready to hear a lot about a weight-loss drug called Mounjaro . Eli Lilly & Co.'s anti-obesity drug has demonstrated significant weight-loss results in clinical trials, so much so that the Wall Street Journal refers to it as the "King Kong" of such drugs. US health regulators...

Eli Lilly Makes a 'Good Guy' Move on Insulin Prices

It's cutting list price for its most commonly prescribed insulin by 70%

(Newser) - Some relief, at long last, for diabetics, who can pay as much as $1,000 a month for the insulin they require: Eli Lilly on Wednesday announced that it will be slashing insulin prices, some immediately and some later this year.
  • Lilly will cut the list price for its most
...

Eli Lilly Faces Questions Over Abortion Stance

Company donated to Indiana legislators behind the restrictions

(Newser) - Eli Lilly's suggestion that it will reconsider adding employees in Indiana in light of its new, nearly total restrictions on abortions might have seemed like it would encourage opponents of the law—one of the state's largest employers exerting leverage on behalf of its position. But the response...

Another Company to Ask FDA to Approve Alzheimer's Drug

Biogen just won approval for its treatment despite experts' dissent

(Newser) - Eli Lilly is nearly ready to take another shot at getting approval for a possible Alzheimer's drug. The drugmaker said Thursday that it plans to submit its potential treatment donanemab to the Food and Drug Administration later this year. The announcement comes a few weeks after the FDA approved...

Experimental Treatment Given to Trump Wins Approval

FDA clears Regeneron for emergency use against COVID

(Newser) - Regeneron's experimental antibody treatment received emergency authorization on Saturday, clearing the way for patients to receive the same therapy given President Trump during his bout with COVID-19. The pharmaceutical company had told the Food and Drug Administration that trial data indicated that the treatment cut the number of medical...

More Good COVID News From the Pharma Industry

Eli Lilly's antibody drug gets emergency use approval

(Newser) - On the same day Pfizer announced its big news on the coming coronavirus vaccine, more positive news from the pharmaceutical industry: Eli Lilly's experimental antibody drug has been given the green light by the FDA. Bamlanivimab, the first such drug to help the immune system fight COVID-19, is now...

Drugmaker Pauses Trial of COVID Antibody Treatment

Eli Lilly says it's for safety reasons, without elaborating

(Newser) - Drugmaker Eli Lilly, working to come up with an antibody treatment for COVID-19, has paused its phase three clinical trials after an independent data safety monitoring board (DSMB) raised concerns. "Safety is of the utmost importance to Lilly," a company spokeswoman said in a statement Tuesday, reports CNBC...

Popular Diabetes Drug Gets Half-Priced Alternative

Eli Lilly announces 'authorized generic' version of Humalog insulin

(Newser) - Drug-maker Eli Lilly is coming out with a half-priced version of its popular insulin Humalog. In fact, the drug called Insulin Lispro will be identical to Humalog except for its packaging and its price—it will cost $137.50 per vial, or 50% less than Humalog, reports the New York ...

Most-Hated Firm in America Has 'String of PR Disasters'

Facebook really gets our goat, per 24/7 Wall St.

(Newser) - The opposite of love may be indifference, but hate is what Americans harbor for the companies that annoy, enrage, and frustrate them. And those firms fall in a variety of sectors, per 24/7 Wall St ., which ranked the most loathed companies in the country based on consumer surveys, data from...

2 Antidepressants Linked to Birth Defects
2 Antidepressants Linked
to Birth Defects 
STUDY SAYS
Jul 10, 2015 4:20 PM CDT

2 Antidepressants Linked to Birth Defects

Paxil and Prozac implicated; newer SSRIs like Zoloft, Celexa cleared

(Newser) - A CDC study of almost 28,000 women has shown links between use of the antidepressants Paxil and Prozac and birth defects, Reuters reports. The study, published in the British Medical Journal , sought to answer long-debated questions about the effect of taking selective serotonin reuptake inhibitors, or SSRIs, during pregnancy,...

Cialis Maker Wants to Sell It Over the Counter

Eli Lilly seeks change for impotence drug

(Newser) - Cialis is already the world's best-selling impotence drug, and its makers hope to significantly ramp up sales by making it available over the counter, reports Reuters . Eli Lilly has struck a deal with French drug-maker Sanofi to sell a non-prescription version, assuming they first win the permission of health...

Disgraced Doctors Land at Big Pharma
 Disgraced Doctors 
 Land at Big Pharma 

investigation
Oct 19, 2010 7:59 AM CDT

Disgraced Doctors Land at Big Pharma

Hundreds of pitchmen found to have blemished records

(Newser) - Pharmaceutical companies say they hire highly respected doctors as their white-coat sales force, peddling their drugs to other physicians. But a Pro Publica investigation has discovered that hundreds of these pitchmen have been accused of professional misconduct, been disciplined by state boards, or lacked credentials. Medical board records in the...

Stories 1 - 20 |  Next >>